indirubin has been researched along with Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hoda, N; Maqbool, M; Mobashir, M | 1 |
| Evdokimov, NM; Kornienko, A; Magedov, IV; McBrayer, D | 1 |
| Alam, MS; Hamid, H; Khan, I; Tantray, MA | 1 |
| Caldon, EC; Tadesse, S; Tilley, W; Wang, S | 1 |
| Chen, X; Chen, Y; Cui, N; Kong, L; Li, S; Li, X; Luo, H; Luo, Z; Wan, S; Wang, X; Yin, F; Zhang, Y | 1 |
| Chan, JY; Hoi, PM; Lee, SM; Wang, Y | 1 |
| Gaboriaud-Kolar, N; Skaltsounis, AL; Vougogiannopoulou, K | 1 |
| Cheng, X; Merz, KH | 1 |
| Chakrabarty, K; Hein, M; Karapetyan, G; Langer, P | 1 |
| Kim, JK; Shin, EK | 1 |
| Skaltsounis, AL; Vougogiannopoulou, K | 1 |
| Davies, J; Kibble, A | 1 |
8 review(s) available for indirubin and Neoplasms
| Article | Year |
|---|---|
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Diabetes Mellitus; Glycogen Synthase Kinase 3; Hippocampus; Humans; Hypoglycemic Agents; Inflammation; Molecular Targeted Therapy; Neoplasms; Protein Kinase Inhibitors | 2016 |
Natural and synthetic bioactive inhibitors of glycogen synthase kinase.
Topics: Alzheimer Disease; Animals; Bipolar Disorder; Clinical Trials as Topic; Diabetes Mellitus; Drug Discovery; Glycogen Synthase Kinase 3; Humans; Models, Molecular; Neoplasms; Patents as Topic; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction | 2017 |
Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Cyclin-Dependent Kinase 2; Drug Design; Humans; Neoplasms; Protein Binding; Protein Conformation; Protein Kinase Inhibitors | 2019 |
New perspective on the dual functions of indirubins in cancer therapy and neuroprotection.
Topics: Animals; Antineoplastic Agents; Cyclin-Dependent Kinases; Glycogen Synthase Kinase 3; Humans; Indoles; Neoplasms; Neurodegenerative Diseases; Neuroprotective Agents; Phosphorylation; Protein Kinase Inhibitors; Structure-Activity Relationship | 2014 |
Indirubin derivatives: a patent review (2010 - present).
Topics: Animals; Antineoplastic Agents; Drug Design; Humans; Indoles; Medicine, Chinese Traditional; Neoplasms; Patents as Topic; Signal Transduction; Solubility | 2015 |
The Role of Indirubins in Inflammation and Associated Tumorigenesis.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Drug Discovery; Drugs, Chinese Herbal; Humans; Indoles; Inflammation; Inflammation Mediators; Medicine, Chinese Traditional; Molecular Structure; Molecular Targeted Therapy; Neoplasms; Phytotherapy; Plants, Medicinal; Protein Kinase Inhibitors; Signal Transduction; Structure-Activity Relationship | 2016 |
Synthesis and bioactivity of carbohydrate derivatives of indigo, its isomers and heteroanalogues.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Female; Glycosides; Glycosylation; Humans; Indigo Carmine; Indoles; Isomerism; Male; Mice; Neoplasms | 2011 |
From Tyrian purple to kinase modulators: naturally halogenated indirubins and synthetic analogues.
Topics: Animals; Antibiotics, Antineoplastic; Brassicaceae; Fabaceae; Gastropoda; Glycogen Synthase Kinase 3; Halogenation; Heart; Humans; Indoles; Kidney; Leukemia; Neoplasms; Neurodegenerative Diseases; Pancreas; Polygonum; Protein Kinase Inhibitors; Stem Cells; Structure-Activity Relationship | 2012 |
4 other study(ies) available for indirubin and Neoplasms
| Article | Year |
|---|---|
Isatin derivatives with activity against apoptosis-resistant cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Isatin; Molecular Structure; Neoplasms; Structure-Activity Relationship | 2016 |
Indirubin derivatives as bifunctional molecules inducing DNA damage and targeting PARP for the treatment of cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; DNA Damage; Neoplasms; Phthalazines; Poly(ADP-ribose) Polymerase Inhibitors | 2023 |
Indirubin derivative E804 inhibits angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Movement; Cell Proliferation; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Male; Mice; Microvessels; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Oximes; Rats; Signal Transduction; Tumor Burden; Vascular Endothelial Growth Factor Receptor-2 | 2012 |
American Association of Cancer Research--95th annual meeting. Kinases. 27-31 March, 2004, Orlando, FL, USA.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Aurora Kinases; Enzyme Inhibitors; Humans; Indoles; Neoplasms; Protein Serine-Threonine Kinases | 2004 |